GeNeuro SA GNRO.PA Stock
GeNeuro SA Price Chart
GeNeuro SA GNRO.PA Financial and Trading Overview
| GeNeuro SA stock price | 1.48 EUR |
| Previous Close | 1.7 EUR |
| Open | 1.71 EUR |
| Bid | 0 EUR x 0 |
| Ask | 0 EUR x 0 |
| Day's Range | 1.7 - 1.71 EUR |
| 52 Week Range | 1.3 - 3.48 EUR |
| Volume | 624 EUR |
| Avg. Volume | 2.1K EUR |
| Market Cap | 43.72M EUR |
| Beta (5Y Monthly) | 0.3 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.54 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.5 EUR |
GNRO.PA Valuation Measures
| Enterprise Value | 43.79M EUR |
| Trailing P/E | N/A |
| Forward P/E | -4.146342 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 28.81356 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -3.717 |
Trading Information
GeNeuro SA Stock Price History
| Beta (5Y Monthly) | 0.3 |
| 52-Week Change | -32.27% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.48 EUR |
| 52 Week Low | 1.3 EUR |
| 50-Day Moving Average | 1.88 EUR |
| 200-Day Moving Average | 1.91 EUR |
GNRO.PA Share Statistics
| Avg. Volume (3 month) | 2.1K EUR |
| Avg. Daily Volume (10-Days) | 918 EUR |
| Shares Outstanding | 24.84M |
| Float | 7.36M |
| Short Ratio | N/A |
| % Held by Insiders | 45.15% |
| % Held by Institutions | 36.94% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -61.52% |
| Return on Equity (ttm) | -386.75% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -11778800 EUR |
| Net Income Avi to Common (ttm) | -12199800 EUR |
| Diluted EPS (ttm) | -0.49 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.59M EUR |
| Total Cash Per Share (mrq) | 0.23 EUR |
| Total Debt (mrq) | 7.12M EUR |
| Total Debt/Equity (mrq) | 486.42 EUR |
| Current Ratio (mrq) | 2.746 |
| Book Value Per Share (mrq) | 0.059 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -13061400 EUR |
| Levered Free Cash Flow (ttm) | -5434300 EUR |
Profile of GeNeuro SA
| Country | France |
| State | N/A |
| City | Plan-les-Ouates |
| Address | 3 chemin du PrE-Fleuri |
| ZIP | 1228 |
| Phone | 41 22 552 48 00 |
| Website | https://www.geneuro.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 19 |
GeNeuro SA, a clinical-stage biopharmaceutical company, develops drugs for the treatment of neurodegenerative and autoimmune diseases. The company's lead therapeutic candidate is temelimab, a monoclonal antibody that neutralizes a pathogenic protein of the HERV-W family; treats type 1 diabetes; and treats chronic inflammatory demyelinating polyneuropathy. It also developing GNK301. In addition, It has cooperative research and development agreements with The National Institute of Neurological Disorders and Stroke to develop novel therapeutic antibodies for the treatment of amyotrophic lateral sclerosis; and Academic centers to develop inflammatory psychosis, as well as a research collaboration agreement with International Center for Infectiology Research; and with Northwestern University for human endogenous retrovirus W envelope protein (HERV-W ENV) in long-haul COVID patients. The company was incorporated in 2006 and is headquartered in Plan-les-Ouates, Switzerland.
Q&A For GeNeuro SA Stock
What is a current GNRO.PA stock price?
GeNeuro SA GNRO.PA stock price today per share is 1.48 EUR.
How to purchase GeNeuro SA stock?
You can buy GNRO.PA shares on the Paris exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for GeNeuro SA?
The stock symbol or ticker of GeNeuro SA is GNRO.PA.
Which industry does the GeNeuro SA company belong to?
The GeNeuro SA industry is Biotechnology.
How many shares does GeNeuro SA have in circulation?
The max supply of GeNeuro SA shares is 29.6M.
What is GeNeuro SA Price to Earnings Ratio (PE Ratio)?
GeNeuro SA PE Ratio is now.
What was GeNeuro SA earnings per share over the trailing 12 months (TTM)?
GeNeuro SA EPS is -0.54 EUR over the trailing 12 months.
Which sector does the GeNeuro SA company belong to?
The GeNeuro SA sector is Healthcare.